Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways

Pharmacology Biochemistry and Behavior

Volumn 136, Issue , 2015, Pages 55-63

  Holzmann, Iandra ^a   Da Silva, Luísa Mota ^a   Corrêa Da Silva, José Afonso ^a   Steimbach, Viviane Miranda Bispo ^a   De Souza, Márcia Maria ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

Depression; Nitric oxide; NMDA; Olfactory bulbectomy; Oxidative stress; Quercetin

Indexed keywords

7 NITROINDAZOLE; ANTIDEPRESSANT AGENT; ARGININE; CYCLIC GMP; FLUOXETINE; GLUTATHIONE; LIPID HYDROPEROXIDE; METHYLENE BLUE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; QUERCETIN; SILDENAFIL; SUPEROXIDE DISMUTASE; 7-NITROINDAZOLE; ANTIOXIDANT; INDAZOLE DERIVATIVE; N METHYLASPARTIC ACID;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; FEMALE; FORCED SWIM TEST; GLUTAMATERGIC SYNAPSE; GROOMING; HIPPOCAMPUS; HYPERACTIVITY; IMMOBILITY; LATENT PERIOD; LOCOMOTION; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; TAIL SUSPENSION TEST; TREATMENT DURATION; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; DRUG POTENTIATION; MALE; METABOLISM; OLFACTORY BULB; SIGNAL TRANSDUCTION; SURGERY;

ANIMALIA; MUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; ARGININE; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FLUOXETINE; HIPPOCAMPUS; INDAZOLES; MALE; METHYLENE BLUE; MICE; N-METHYLASPARTATE; OLFACTORY BULB; OXIDATIVE STRESS; QUERCETIN; SIGNAL TRANSDUCTION; SILDENAFIL CITRATE;

EID: 84937575629     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.07.003     Document Type: Article

References (88)

1. B.A. Abdel-Wahaba, and R.H. Salamab Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice Pharmacol. Biochem. Behav. 100 2011 59 65
2. M. Altemusa, N. Sarvaiya, and C.N. Epperson Sex differences in anxiety and depression clinical perspectives Front. Neuroendocrinol. 35 2014 320 330
3. L. Altomonte, F. Atzeni, G. Leardini, and A. Marsico Fibromyalgia syndrome: preventive, social and economic aspects Reumatismo 60 2008 70 78
4. M. Anjaneyulu, K. Chopra, and I. Kaur Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice J. Med. Food 4 2003 391 395
5. B. Atanasova, J.E.L. Graux, W. Hage, C. Hommet, V. Camus, and C. Belzung Olfaction: a potential cognitive marker of psychiatric disorders Neurosci. Biobehav. Rev. 32 2008 1315 1325
6. D. Bennabi, B. Aouizerate, W. El-Hage, O. Doumy, F. Moliere, P. Courtet, I. Nieto, F. Bellivier, M. Bubrovsky, G. Vaiva, J. Holztmann, T. Bougerol, R. Richieri, C. Lancon, V. Camus, G. Saba, F. Haesbaert, T. d'Amato, T. Charpeaud, P.M. Llorca, M. Leboyer, and E. Haffen Risk factors for treatment resistance in unipolar depression: a systematic review J. Affect. Disord. 171 2015 137 141
7. P. Bhutada, Y. Mundhada, K. Bansod, A. Ubgade, Umathe S. QuaziM, and D. Mundhada Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 955 960
8. A. Bishop, and J.E. Anderson NO signaling in the CNS: from the physiological to the pathological Toxicology 208 2005 193 205
9. Y. Borre, E. Bosman, S. Lemstra, K.G. Westphal, B. Olivier, and R.S. Oosting Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration Neuropharmacology 62 2012 2010 2017
10. P.S. Brocardo, J. Budni, K.R. Lobato, M.P. Kaster, and A.L.S. Rodrigues Antidepressant-like effect of folic acid: involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway Eur. J. Pharmacol. 598 2008 37 42
11. J. Brunet, C.M. Sabiston, E. O'Loughlin, M. Chaiton, N.C.P. Low, and J.L. O'Loughlin Symptoms of depression are longitudinally associated with sedentary behaviors among young men but not among young women Prev. Med. 60 2014 16 20
12. D.P. Cain The role of the olfactory bulb in limbic mechanisms Psychol. Bull. 81 1974 654 671
13. D.J. Calcagnetti, L.A. Quatrella, and M.D. Schechter Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference Physiol. Behav. 59 1996 597 604
14. E. Castren, V. Voikar, and T. Rantamaki Role of neurotrophic factors in depression Curr. Opin. Pharmacol. 7 2007 18 21
15. B.C. Detanico, A.L. Piato, J.J. Freitas, F.L. Lhullier, M.P. Hidalgo, W. Caumo, and E. Elisabetsky Antidepressant-like effects of melatonin in the mouse chronic mild stress model Eur. J. Pharmacol. 607 2009 121 125
16. A. Dhir, and S.K. Kulkarni Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor Eur. J. Pharmacol. 568 2007 177 185
17. T.N. Douma, Y. Borre, H. Hendriksen, B. Olivier, and R.S. Oosting Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats Psychopharmacology 216 2012 537 544
18. S.S. Dovichi, and F.M. Lajolo Flavonoids and their relationship to diseases of the central nervous system Nutr. J. Braz. Soc. Food. Nutr. 36 2011 123 135
19. M.P. Fleck, M.T. Berlim, B. Lafer, E.B. Sougey, J.A. Del Porto, M.A. Brasil, M.F. Juruena, and L.A. Hetem Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão Rev. Bras. Psiquiatr. 31 2009 7 17
20. L. Flohe Glutathione peroxidase: enzymology and biological aspects Klin. Wochenschr. 49 1971 669 683
21. P. Galecki, J. Szemraj, M. Bienkiewicz, A. Florkowski, and E. Galecka Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment Pharmacol. Rep. 61 2009 436 447
22. M. Ghasemi, H. Sadeghipour, A. Mosleh, H.R. Sadeghipour, A.R. Mani, and A.R. Dehpour Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test Eur. Neuropsychopharmacol. 18 2008 323 332
23. M. Ghasemi, L. Montaser-Kouhsari, H. Shafarodi, B.G. Nezami, F. Ebrahimi, and A.R. Dehpour NMDA/receptor nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test Psychopharmacology 206 2009 325 333
24. P. Gosek, M. Chojnacka, P. Bieńkowski, and I. Swiecicki Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression Psychiatr. Pol. 46 2012 283 294
25. C. Habel, N. Feeley, B. Hayton, L. Bell, and P. Zelkowitz Causes of women's postpartum depression symptoms: Men's and women's perceptions Midwifery 31 2015 728 734
26. N. Haleagrahara, A. Radhakrishnan, N. Lee, and P. Kumar Flavonoid quercetin protects against swimming stress-induced changes in oxidative biomarkers in the hypothalamus of rats Eur. J. Pharmacol. 621 2009 46 52
27. A. Harkin, T.J. Connor, M.S.T. Walsh, N. John, and J.P. Kelly Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors Neuropharmacology 44 2003 616 623
28. R. Hellweg, M. Züger, K. Fink, H. Hörtnagl, and P. Gass Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas Neurobiol. Dis. 25 2007 1 7
29. C.J. Herzog, B. Czéh, S. Corbach, W. Wuttke, O. Schulte-Herbrüggen, R. Hellweg, G. Flügge, and E. Fuchs Chronic social instability stress in female rats: a potential animal model for female depression Neuroscience 159 2009 982 992
30. E.S. Higgins, and M.S. George Neurociência para psiquiatria clínica: a fisiopatologia do comportamento e a doença mental 2010 Artmed Porto Alegre
31. S.A. Hiles, A.L. Baker, T. Malmanche, M. McEvoy, M. Boyle, and J. Attia Unhealthy lifestyle may increase later depression via inflammation in older women but not men J. Psychiatr. Res. 63 2015 65 74
32. Y.J. Hoa, Y.C. Chang, T.M. Liu, M.Y. Tai, C.S. Wong, and Y.F. Tsai Striatal glutamate release during novelty exposure-induced hyperactivity in olfactory bulbectomized rats Neurosci. Lett. 287 2000 117 120
33. E. Isingrini, V. Camus, A.M. Guisquet, M. Pingaud, S. Devers, and C. Belzung Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice PLoS ONE 5 2010 104
34. J. Jarosik, B. Legutko, K. Unsicker, V.B. Und, and O. Halbach Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy Exp. Neurol. 204 2007 20 28
35. J.A. Jesberger, and J.S. Richardson Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? Int. J. Neurosci. 38 1988 241 265
36. Y. Jiang, A.C.S. Woollard, and S.P. Wolff Lipid hydroperoxide measurement by oxidation of Fe + 2 in the presence of xilenol orange. Comparison with the TBA assay and an iodometric method Lipids 26 1991 853 856
37. T.K. Kao, Y.C. Ou, S.L. Raung, C.Y. Lai, S.L. Liao, and C.J. Chen Inhibition of nitric oxide production by quercetin in endotoxin/cytokine-stimulated microglia Life Sci. 86 2010 315 321
38. S. Katarzyna, N. Dorota, P. Ewa, and W. Piotr Influence of the phosphodiesterase type 5 inhibitor, sildenafil, on antidepressant-like activity of magnesium in the forced swim test in mice Pharmacol. Rep. 64 2012 205 211
39. K. Kawabata, Y. Kawai, and J. Terao Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in Wistar rats J. Nutr. Biochem. 21 2010 374 380
40. J.P. Kelly, A.S. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol. Ther. 74 1997 299 316
41. R.C. Kessler Epidemiology of women and depression J. Affect. Disord. 74 2003 5 13
42. S.D. Khanzode, G.N. Dakhale, S.S. Khanzode, A. Saoji, and R. Palasodkar Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors Redox Rep. 8 2003 365 370
43. M.S. Kim, M.K. Kim, K.S. Kim, J.H. Chung, S.J. Kim, J.H. Kim, J.R. Kim, J. Lee, B.P. Yu, and H.Y. Chung Cytotoxicity of 1,2-diacetylbenzene in human neuroblastoma SHSY5Y cells is mediated by oxidative stress Toxicology 243 2008 216 223
44. V.O. Kotan, E. Sarandol, E. Kirhan, G. Ozkaya, and S. Kirli Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 1284 1290
45. A. Kumar, and R. Goyal Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice J. Med. Food 11 2008 469 473
46. M.H. Larsen, J.D. Mikkelsen, A. Hay-Schmidt, and C. Sandi Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment J. Psychiatr. Res. 44 2010 808 816
47. S.E. Laursen, and J.K. Belknap Intracerebroventricular injections in mice. Some methodological refinements J. Pharmacol. Methods 16 1986 355 357
48. B. Lee, I. Shim, H. Lee, and D.H. Hahm Effect of ginsenoside Re on depression- and anxiety-like behaviors and cognition memory deficit induced by repeated immobilization in rats J. Microbiol. Biotechnol. 22 2012 708 720
49. B.E. Leonard, and M. Tuite Anatomical, physiological and behavioral aspects of olfactory bulbectomy in the rat Int. Rev. Neurobiol. 22 1981 251 286
50. D.G. Machado, M.P. Cunha, V.B. Neis, G.O. Balen, A. Colla, J. Grando, P.S. Brocardo, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy Pharmacol. Biochem. Behav. 103 2012 220 229
51. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 676 692
52. A. Mar, E. Spreekmeester, and J. Rochford Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat Psychopharmacology 150 2000 52 60
53. A. Mar, E. Spreekmeester, and J. Rochford Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety Pharmacol. Biochem. Behav. 73 2002 703 712
54. S. Marklund, and G. Marklund Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase Eur. J. Biochem. 47 1974 469 474
55. W.N. Marsden Stressor-induced NMDAR dysfunction as a unifying hypothesis for the etiology, pathogenesis and comorbidity of clinical depression Med. Hypotheses 77 2011 508 528
56. T.M. Michel, S. Frangou, D. Thiemeyer, S. Camara, J. Jecel, K. Nara, A. Brunklaus, R. Zoechling, and P. Riederer Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - a post-mortem study Psychiatry Res. 151 2007 145 150
57. J.C. Morales-Medina, Y. Dumont, P. Bonaventure, and R. Quirion Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced antidepressant-like behaviors in olfactory bulbectomized rat Neuropeptides 46 2012 329 334
58. J.C. Morales-Medina, I. Juarez, E. Venancio-Garcia, S.N. Cabrera, C. Menard, W. Yu, G. Flores, N. Mechawar, and R. Quirion Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat Neuroscience 236 2013 233 243
59. M. Moretti, A.E. Freitas, J. Budni, S.C.P. Fernandes, G.O. Balen, and A.L.S. Rodrigues Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test Behav. Brain Res. 225 2011 328 333
60. O. Nakagawasai, S. Hozumi, K. Tan-no, F. Niijima, Y. Arai, H. Yasuhara, and Tadano Immunohistochemical fluorescence intensity reduction of brain somatostatin in the impairment of learning and memory-related behaviour induced by olfactory bulbectomy Behav. Brain Res. 142 2003 63 67
61. S. Negoias, I. Croy, J. Gerber, S. Puschmann, K. Petrowski, P. Joraschky, and T. Hummel Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression Neuroscience 169 2010 415 421
62. A. Paulke, M. Schubert-Zsilavecz, and M. Wurglics Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 832 2006 109 113
63. B. Pochwat, M. Sowa-Kucma, K. Kotarska, P. Misztak, G. Nowak, and B. Szewczyk Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway Psychopharmacology 232 2015 355 367
64. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressant Arch. Int. Pharmacodyn. Ther. 229 1977 327 336
65. C. Pudell, B.A. Vicente, A.M. Delattre, B. Carabelli, M.A. Mori, D. Suchecki, R.B. Machado, S.M. Zanata, J.V. Visentainer, O.O.S. Junior, M.S. Lima, and A.C. Ferraz Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomized rats Eur. J. Neurosci. 39 2014 266 274
66. G. Racagni, and M. Popoli The pharmacological properties of antidepressants Int. Clin. Psychopharmacol. 25 2010 117 131
67. D.K. Rieger, A.P. Costa, J. Budni, M. Moretti, S.G.R. Barbosa, K.S. Nascimento, E.H. Teixeira, B.S. Cavada, and Leal R.B. RodriguesALS Antidepressant-like effect of Canavalia brasiliensis Pharmacol. Biochem. Behav. 122 2014 53 56
68. P. Rinwa, and A. Kumar Quercetin suppress microglial neuroinflammatory response and induce antidepressant-like effect in olfactory bulbectomized rats Neuroscience 255 2013 86 98
69. T. Romeas, M.C. Morissette, O. Mnie-Filali, G. Piñeyro, and S.M. Boye Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression Psychopharmacology 205 2009 293 303
70. M. Romero, R. Jiménez, B. Hurtado, J.M. Moreno, I. Rodríguez-Gómez, and R. López-Sepúlveda Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats Eur. J. Pharmacol. 627 2010 242 250
71. A. Saitoh, N. Hirose, M. Yamada, M. Yamada, C. Nozaki, T. Oka, and J. Kamei Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy J. Pharmacol. Sci. 102 2006 377 386
72. J. Sedlak, and R.H. Lindsay Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal. Biochem. 24 1968 192 205
73. C. Song, and B.E. Leonard The olfactory bulbectomised rat as a model of depression Neurosci. Biobehav. Rev. 29 2005 627 647
74. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology. 85 1985 367 370
75. H.S. Stock, K. Ford, and M.A. Wilson Gender and gonadal hormone effects in the olfactory bulbectomy animal model of depression Pharmacol. Biochem. Behav. 67 2000 183 191
76. V.S. Tomaz, R.C. Cordeiro, A.M. Costa, D.F. de Lucena, H.V. Nobre Júnior, F.C. de Sousa, S.M. Vasconcelos, M.L. Vale, J. Quevedo, and D. Macêdo Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice Neuroscience 268 2014 236 246
77. C.M. Van Der Feltz-Cornelis, J. Nuyen, C. Stoop, J. Chan, A.M. Jacobson, W. Katon, F. Snoek, and N. Sartorius Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis Gen. Hosp. Psychiatry 32 2010 380 395
78. H. Van Riezen, and B.E. Leonard Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats Pharmacol Ther. 47 1990 21 34
79. P. Vieyra-Reyes, Y.S. Mineur, M.R. Picciotto, I. Túnez, R. Vidaltamayo, and R. Drucker-Colín Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression Brain Res Bull. 77 2008 13 18
80. D. Wang, Y. Noda, H. Tsunekawa, Y. Zhou, M. Miyazaki, K. Senzaki, and T. Nabeshima Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety Behav. Brain Res. 178 2007 262 273
81. G. Wegener, V. Volke, and R. Rosenberg Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo Br. J. Pharmacol. 130 2000 575 580
82. G. Wegener, V. Volke, B.H. Harvey, and R. Rosenberg Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity Brain Res. 959 2003 128 134
83. P. Willner, J.S. Krügerb, and C. Belzungc The neurobiology of depression and antidepressant action Neurosci. Biobehav. Rev. 37 2013 2331 2371
84. C. Xu, J. Teng, W. Chen, Q. Ge, Z. Yang, and C. Yu 20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 1402 1411
85. I. Yalcin, F. Aksu, and C. Belzung Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol Eur. J. Pharmacol. 514 2005 165 174
86. A.L. Zeni, A.D. Zomkowski, T. Dal-Cim, M. Maraschin, A.L. Rodrigues, and C.I. Tasca Antidepressant-like and neuroprotective effects of Aloysia gratissima: investigation of involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway J. Ethnopharmacol. 137 2011 864 874
87. A.D. Zomkowski, D.F. Engel, N.H. Gabilan, and A.L.S. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test Eur. Neurophysiol. 20 2010 793 801
88. M. Zueger, A. Urani, S. Chourbaji, C. Zacher, M. Roche, A. Harkin, and P. Gass Olfactory bulbectomy in mice induces alterations in exploratory behavior Neurosci. Lett. 374 2005 142 146